-
1دورية أكاديمية
المؤلفون: Tungjitviboonkun, SongpholAff1, Aff2, IDs00277024058247_cor1, Bumrungratanayos, Naharuthai, Jitwimungsanon, Jedsadakorn, Kheamakulvanich, Thanat, Siramongkholkarn, Smuch
المصدر: Annals of Hematology. 103(9):3357-3368
-
2دورية أكاديمية
المؤلفون: Sonya J. Malavez-Cajigas, Fabiana I. Marini-Martinez, Mercedes Lacourt-Ventura, Karla J. Rosario-Pacheco, Natalia M. Ortiz-Perez, Bethzaly Velazquez-Perez, Wilfredo De Jesús-Rojas, Daniel S. Chertow, Jeffrey R. Strich, Marcos J. Ramos-Benítez
المصدر: Heliyon, Vol 10, Iss 16, Pp e36386- (2024)
مصطلحات موضوعية: Neutrophils, Neutrophil Extracellular Traps, Lipopolysaccharide, SYK inhibitor, Human leukemia cell line, HL-60, Science (General), Q1-390, Social sciences (General), H1-99
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Reem Karmali, Frederique St‐Pierre, Shuo Ma, Kelly D. Foster, Jason Kaplan, Xinlei Mi, Barbara Pro, Jane N. Winter, Leo I. Gordon
المصدر: eJHaem, Vol 4, Iss 1, Pp 108-114 (2023)
مصطلحات موضوعية: aggressive non‐Hodgkin's lymphoma, diffuse large B‐cell lymphoma, mivavotinib, SYK inhibitor, TAK‐659, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2688-6146
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Vikas Kumar, Shraddha Parate, Danishuddin, Amir Zeb, Pooja Singh, Gihwan Lee, Tae Sung Jung, Keun Woo Lee, Min Woo Ha
المصدر: Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
مصطلحات موضوعية: SYK inhibitor, 3D QSAR, pharmacophore, autoimmune diseases, molecular docking, MD simulation, Microbiology, QR1-502
وصف الملف: electronic resource
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: Gordon, Leo I, Karmali, Reem, Kaplan, Jason B, Popat, Rakesh, Burris, Howard A, Ferrari, Silvia, Madan, Sumit, Patel, Manish R, Gritti, Giuseppe, El-Sharkawi, Dima, Chau, F Ian, Radford, John, de Oteyza, Jaime Pérez, Zinzani, Pier Luigi, Iyer, Swaminathan P, Townsend, William, Miao, Harry, Proscurshim, Igor, Wang, Shining, Katyayan, Shilpi, Yuan, Ying, Zhu, Jiaxi, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc
المساهمون: Institut Català de la Salut, [Gordon LI, Karmali R, Kaplan JB] Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA. [Popat R] Department of Haematology, NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK. [Burris HA 3rd] Drug Development, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, USA. [Ferrari S] Dipartimento di Oncologia ed Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy. [Carpio C] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Bosch F] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Gordon, L I, Karmali, R, Kaplan, J B, Popat, R, Burris, H A, Ferrari, S, Madan, S, Patel, M R, Gritti, G, El-Sharkawi, D, Chau, F I, Radford, J, de Oteyza, J P, Zinzani, P L, Iyer, S P, Townsend, W, Miao, H, Proscurshim, I, Wang, S, Katyayan, S, Yuan, Y, Zhu, J, Stumpo, K, Shou, Y, Carpio, C & Bosch, F 2023, ' Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma : updated data with mivavotinib (TAK-659/CB-659) ', Oncotarget, vol. 14, pp. 57-70 . https://doi.org/10.18632/oncotarget.28352
Scientiaمصطلحات موضوعية: Cèl·lules B - Tumors - Tractament, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Sang - Malalties - Tractament, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Protein Kinase Inhibitors/adverse effects, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS], enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso [ENFERMEDADES], Humans, Syk Kinase, Other subheadings::/therapeutic use [Other subheadings], neoplasias::neoplasias por localización::neoplasias hematológicas [ENFERMEDADES], TAK-659, Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse [DISEASES], Vascular Endothelial Growth Factor Receptor-1, Manchester Cancer Research Centre, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], Otros calificadores::/uso terapéutico [Otros calificadores], ResearchInstitutes_Networks_Beacons/mcrc, Non-Hodgkin's lymphoma, Neoplasms::Neoplasms by Site::Hematologic Neoplasms [DISEASES], SYK inhibitor, Treatment Outcome, Oncology, DLBCL, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Relapsed/refractory, Proteïnes quinases - Inhibidors - Ús terapèutic, Lymphoma, Large B-Cell, Diffuse/pathology
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611458e735d4ba1168636765aa9dcd81
https://ddd.uab.cat/record/271599
Find this article in full text from Springer Verlag. 
Full Text Finder